Research Programme - dermatologic disorder therapeutics - Azora Therapeutics
Alternative Names: skin diseases therapeutics - Azora TherapeuticsLatest Information Update: 06 Jan 2023
At a glance
- Originator Azora Therapeutics
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Aryl hydrocarbon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders
Most Recent Events
- 27 Dec 2022 Early research in Skin disorders in USA (unspecified route) (Azora Therapeutics pipeline, December 2022)